Heron Therapeutics (HRTX) Earnings Analysis
Heron Therapeutics (HRTX) next reports earnings on 2026-08-14, consensus EPS -0.02 USD. Last quarter (2026-05-11) it missed with EPS -0.04 USD vs -0.03 USD est (-33.3%). It has beaten estimates in 2/4 recent quarters (50%). Trailing P/E -2.64.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does HRTX next report earnings?
| Next earnings date | 2026-08-14 |
|---|---|
| Consensus EPS estimate | -0.02 USD |
| Revenue estimate | 0.04B |
HRTX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.04 USD | -0.03 USD | -33.3% | Miss |
| 2026-02-26 | -0.02 USD | -0.03 USD | +33.3% | Beat |
| 2025-08-08 | -0.02 USD | -0.01 USD | -100% | Miss |
| 2025-02-27 | 0.02 USD | -0.03 USD | +166.7% | Beat |
Beat rate: 2/4 (50%) over reported quarters with consensus data.
HRTX valuation and analyst view
| Trailing P/E | -2.64 |
|---|---|
| Trailing EPS | -0.16315 USD |
| Price / book | 9.71 |
| Dividend yield | 0.00% |
| Market cap | 0.08B |
| Analyst consensus | Buy (18 buy / 1 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Heron Therapeutics (HRTX)'s next earnings date?
Heron Therapeutics is next scheduled to report on 2026-08-14, with a consensus EPS estimate of -0.02 USD and revenue estimate of 0.04B.
Did HRTX beat earnings last quarter?
In its 2026-05-11 report, HRTX posted EPS of -0.04 USD versus a -0.03 USD estimate — a miss of 33.3%.
What is HRTX's earnings track record?
Over the last 4 reported quarters with consensus data, HRTX beat estimates 2 times (50%).
What is HRTX's current P/E ratio and EPS?
HRTX trades at a trailing P/E of -2.64 on trailing EPS of -0.16315134513778304 USD.
What do analysts rate HRTX?
Analyst consensus is "Buy" across 19 ratings (0 strong buy, 18 buy, 1 hold, 0 sell, 0 strong sell).